Clinical size is a poor predictor of invasion in melanoma of the lentigo maligna type.
By: Cristian Navarrete-Dechent, Saud Aleissa, Karen Connolly, Brian P Hibler, Stephen W Dusza, Anthony M Rossi, Erica Lee, Kishwer S Nehal

Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Dermatology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.
2020-08-23; doi: 10.1016/j.jaad.2020.10.023
Abstract

Background

There are no well-defined clinical factors to predict the risk of occult invasion in melanoma of the lentigo maligna type (LM) prior to complete histopathologic analysis.

Objective

To evaluate whether clinical size was a predictor of invasion in LM and subclinical extension.

Methods

Consecutive cases of LM were recorded in a prospectively maintained database from 2006 to 2019. Patient and tumor data were recorded during initial evaluation. 'LM clinical area' was calculated in square millimeters (length x width). All patients were treated with staged excision.

Results

We included 600 patients. Mean age was 65.9 years (SD 12.3; range 27 - 95 years); 62.8% (n=377) were males. The mean LM clinical area was 128.32 mm2 for in situ lesions vs 200.14 mm for invasive lesions (p=0.1). Based on quantile regression, the median margin required for complete removal increased with LM clinical area.

Limitations

study performed in a tertiary cancer center with possible referral bias and more complex cases.

Conclusions

LM can present with variable clinical size which may correlate with subclinical extension; however, the presence of invasion is not well estimated by LM clinical area.



Copyright © 2020. Published by Elsevier Inc.

PMID:33096134






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements